NCT05480046 Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a Relapse Status COMPLETED Phase N/A
NCT05473741 Risk of Breakthrough Symptoms With Long-Acting Injectable Medications Status COMPLETED Phase N/A
NCT05469815 Lost Children Society (LCS), Online Therapeutic Tabletop Role-playing Game for Early-onset Schizophrenia Patients Status WITHDRAWN Phase NA
NCT05464563 Study by Electroencephalography of the Link Between the Lack of Self-compassion and the Disorder of Empathy in Schizophrenia Status COMPLETED Phase NA
NCT05463770 A Clinical Study That Will Assess the Effect of SEP-363856 and Prior Antipsychotic (PA) Standard of Care on Glucose and Regulation of Insulin in Patients With Schizophrenia Status COMPLETED Phase PHASE1
NCT05457127 Obstructive Sleep Apnea Treatment in Serious Mental Illness Status NOT_YET_RECRUITING Phase NA
NCT05449977 Evaluation of Physical Activity, Physical Fitness, and Quality of Life in Patients With Schizophrenia Status COMPLETED Phase N/A
NCT05448430 iTBS Can Increase Frontal Dopamine Release in PET Dopamine Imaging. Status UNKNOWN Phase NA
NCT05443724 A Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With Schizophrenia Status COMPLETED Phase PHASE2
NCT05440955 tDCS for Cognitive Impairment Associated With Recent-onset Schizophrenia Status NOT_YET_RECRUITING Phase NA
NCT05438160 Exploratory Study of a Digital Therapeutics in People With Schizophrenia Status COMPLETED Phase NA
NCT05435300 Does tDCS Change Synaptic Density in the Brains of Patients With Schizophrenia Status RECRUITING Phase N/A
NCT05413486 Sleep, Obesity and Mental Disease - Biological Markers for the Evaluation of Circadian Rhythmicity Status RECRUITING Phase N/A
NCT05406440 A Study of Elpipodect (MK-8189) in Participants With Schizophrenia (MK-8189-014) Status COMPLETED Phase PHASE1
NCT05402111 A Clinical Study That Will Assess How Food Moves Through the Stomach and Effects Blood Glucose Levels in Subjects With Schizophrenia Taking SEP-363856 or and Prior Antipsychotic (PA) Standard Status COMPLETED Phase PHASE1
NCT05389787 Impact of Cerebellar TMS on Brain and Cognitive Functions in Schizophrenia: a Pilot Study Status RECRUITING Phase NA